Navigation Links
Watson to Acquire Arrow Group
Date:6/17/2009

manufacturing network, including facilities in Canada, Malta and Brazil, will further expand Watson's global supply chain."

Key Benefits of the Transaction Include:

  • Expanded Commercial Footprint: Arrow's global commercial footprint in many established and emerging countries allows Watson to introduce its generic and brand products into these markets. Arrow's manufacturing network will further expand Watson's global supply chain. Additionally, Arrow owns an extensive portfolio of product registrations in regions where it does not yet have a commercial presence. This will allow Watson to rapidly and efficiently expand its sales and marketing operations into these markets.
  • Strong Product Portfolio and Pipeline: Since 2000, Arrow has launched an extensive portfolio of products into more than 20 countries. This includes more than 50 molecules developed internally. In addition, Arrow expects approval of 40 new molecules over the next three years. Successful patent challenges and settlements will allow for significant U.S. generic product launches over the next three years, including exclusive U.S. rights to launch the authorized generic version of Lipitor(R) (atorvastatin) in November 2011.
  • Provides Foundation for Generic Biologics: Arrow owns approximately 36% of Eden Biodesign, a biopharmaceutical company that provides development and manufacturing services to early stage biotechnology companies. Watson believes Eden will provide the operational expertise and manufacturing capability to support its long term investment in generic biologics.
  • Efficient Execution and Integration: Arrow's global footprint and product portfolio has minimal overlap with Watson's and the Company anticipates that the integration of the two businesses will be very manageable. Arrow brings a global sales, legal and regulatory infrastructure to complement Watson'
    '/>"/>

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Watson Files FDA Application for Generic Mucinex(R) D
2. Watson Launches GELNIQUE(TM) (oxybutynin chloride) Gel 10%, First and Only Topical Gel for Overactive Bladder (OAB)
3. Watson-Marlow Releases Informative Video Featuring Showcased High Purity Pumps, Tubing and Fillers at Interphex 2009
4. Watson Pharmaceuticals Reports First Quarter 2009 Results; Raises 2009 Outlook
5. Watson Files FDA Applications for Generic Mucinex(R)
6. Watson to Host and Webcast Investment Community Meeting at American Urological Association Annual Meeting
7. Companies Continue To Add Wellness Programs, Watson Wyatt/National Business Group On Health Survey Finds
8. Mark G. Watson Named Executive Director of Radiological Society of North America
9. Watson Pharmaceuticals and Elan Settle Lawsuit Over Naproxen Sodium
10. Watson Pharmaceuticals Reports Fourth Quarter and Full Year 2008 Results; Provides 2009 Outlook
11. Watson Acknowledges Federal Trade Commission Action Regarding AndroGel Patent Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Follow us on LinkedIn ... pandemic proportions in both developed and developing countries alike. ... habits, growing preference for processed food, and sedentary lifestyles ... not regarded a disease by itself, obesity is known ... as diabetes, hypertension, cardiovascular risks as well as cancer. ...
(Date:7/23/2014)... 2014 Follow us on ... in the marketing mix, with its benefits ranging ... customers’ purchase decision. In a competitive market environment, ... packaging provides ample opportunities for sales growth. Manufacturers ... technologies such as blister and other high visibility ...
(Date:7/23/2014)... Hemodialysis equipment is the most widely used ... acute or chronic renal failure. , The Chinese hemodialysis ... European, American and Japanese enterprises. In 2013, the import ... growing demand for hemodialysis equipment in China, its import ... in 2009-2013. Germany, Sweden and Japan as the main ...
(Date:7/23/2014)... July 23, 2014 Throughout the month of ... announced plenty of new items. Also, it is hosting a ... unveiled its collection of short summer beach wedding dresses ... of popular styles in it. Additionally, these outfits are now ... , “As one of the world’s leading suppliers, LunaDress ...
(Date:7/23/2014)... Upland, California (PRWEB) July 23, 2014 ... flavorful home-delivered fully prepared healthy gourmet cuisine, received rave ... at the LA’s Largest Mixer. Mixer attendees were amazed ... Thursday, July 17th 2014, World Gardens Café, the premier ... gourmet cuisine, had a booth at Dave Linden’s LA’s ...
Breaking Medicine News(10 mins):Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 2Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 3Health News:Surging Obesity Rates Drives Demand for Bariatric (Obesity) Surgical Devices, According to New Report by Global Industry Analysts, Inc. 4Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Increasing Focus on Packaging as a Marketing Tool Drives the Blister & Other High Visibility Packaging Market, According to New Report by Global Industry Analysts, Inc. 4Health News:China Hemodialysis Equipment Market (Import & Export) Report 2013-2016 Now Available at ChinaMarketResearchReports.com 2Health News:China Hemodialysis Equipment Market (Import & Export) Report 2013-2016 Now Available at ChinaMarketResearchReports.com 3Health News:China Hemodialysis Equipment Market (Import & Export) Report 2013-2016 Now Available at ChinaMarketResearchReports.com 4Health News:LunaDress Continues To Enrich Product Line By Offering Short Summer Beach Wedding Dresses 2Health News:Healthy Food Gets Rave Reviews at LA’s Largest Mixer 2
... for growing mental health issues in the U.S. & ... (FBN) announces the launch of a new web ... resource for individuals who need support for and information ... mission is to provide an informative, supportive community supplemented ...
... Nichols Institute Diagnostics, Pleads Guilty to Felony Misbranding ... its subsidiary, Nichols Institute Diagnostics (NID), have entered ... to resolve criminal and civil claims concerning various ... marketed and sold to laboratories throughout the country ...
... the April 16 issue of the journal "Neuron," was conducted ... the Stanford University School of Medicine, who characterized their finding ... , ... (Vocus) April 15, 2009 -- ...
... April 15 TopBestPennyStocks.com is pleased to ... are interested in stocks on the move and in the news ... http://www.TopBestPennyStocks.com Today,s focused alerts include: ChinaCast Education (Nasdaq: ... VM ), Netflix Inc. (Nasdaq: NFLX ), Pfizer Inc. ...
... the disease, , , WEDNESDAY, April 15 (HealthDay News) ... the tracking of changes in cancer cells, according ... Medicine. , The technology uses specially designed dye-containing ... or on a single cell. , Current single-flow ...
... invasive surgical techniques -- most notably, laparoscopy -- ... option across the United States for people with ... newer, third option is a hybrid -- hand-assisted ... effective and compares favorably with standard laparoscopy, according ...
Cached Medicine News:Health News:Feel Better Network Launches Web Site for Relief in Challenging Times 2Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 2Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 3Health News:Quest Diagnostics to Pay U.S. $302 Million to Resolve Allegations That a Subsidiary Sold Misbranded Test Kits 4Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 2Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 3Health News:UCSF, Stanford Study Reveals Neural Networks Targeted in Brain Diseases 4Health News:TopBestPennyStocks.com Issues Technical Trade Alerts on Hot Stocks in the Market Today: CAST, VM, NFLX, PFE, AA, & COF 2Health News:Helping hand of hybrid surgery benefits colorectal patients 2
(Date:7/22/2014)... WASHINGTON , July 22, 2014  Edwards Lifesciences ... in the science of heart valves and hemodynamic monitoring, ... Mussallem today served as an expert panelist at ... Committee,s Subcommittee on Health to discuss medical device innovation ... Barriers to Ongoing Evidence Development and Communication." ...
(Date:7/22/2014)...  Decision Resources Group finds that the market for interventional ... remain relatively stagnant at a value of around $80 million ... intervention (PCI) volumes are growing faster in Canada ... the United States and Europe ... increase in penetration of PCI procedures relative to coronary artery ...
(Date:7/22/2014)... -- The number of people overdosing from opioid prescription ... percent of the workforce has misused prescription painkillers, according ... making opioid use a serious threat to employee safety. ... correct dosage with a valid prescription, subtle impairment may ... Safety Council released a guide for employers, ...
Breaking Medicine Technology:Edwards' CEO Invited To Address Congress On Opportunities To Revitalize Medical Device Innovation 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 2The Canadian Interventional Cardiology Device Market Will Remain Relatively Stagnant Through 2022 at Around $80 Million 35 things employers should know about prescription painkiller use 25 things employers should know about prescription painkiller use 3
... Corporation (Nasdaq: DNDN ) today reported results for ... quarter ended September 30, 2010 was $20.2 million compared to ... the nine months ended September 30, 2010 was $23.1 million ... 2009.   Revenue from sales of PROVENGE® (sipuleucel-T) ...
... EMERYVILLE, Calif., Nov. 3, 2010 Onyx Pharmaceuticals, ... results for the third quarter 2010. Onyx reported non-GAAP net ... the third quarter 2010 compared to non-GAAP net income of ... period in 2009. Non-GAAP net income excludes, among other items, ...
Cached Medicine Technology:Dendreon Reports Third Quarter 2010 Financial Results 2Dendreon Reports Third Quarter 2010 Financial Results 3Dendreon Reports Third Quarter 2010 Financial Results 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 2Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 3Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 4Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 5Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 6Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 7Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 8Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 9Onyx Pharmaceuticals Reports Third Quarter 2010 Financial Results; Japan License Leverages Worldwide Potential of Carfilzomib and Contributes $59.2 Million of License Revenue 10
... Merlin is a superior full-color, auto-focus, ... vision user in mind, Merlin enables the ... black and white, high contrast positive or ... video magnifier, this optional feature enables the ...
... purpose incubators designed to provide ... uniformity required for the most ... microprocessor controlled incubators feature push-button ... digital display, and built-in over-temperature ...
... Precision Economy Incubators available in five different ... of 1.4 cu. Ft. (39 liters), 2.5 ... ft. (129 liters. Equally important, Precision Economy ... excellent temperature sensitivity, stability, and uniformity. As ...
Aspheric diagnostic lens. 90D...
Medicine Products: